Baseline characteristics of all aneurysm and control subjects
| Aneurysm group (n=63) | Controls (n=19) | |
| Demographics | ||
| Male/female | 56/7 | 17/2 |
| Age, years | 76.1±6.8 | 69.4±5.8 |
| Aneurysm diameter, cm | 4.33±0.73 | – |
| Risk factors | ||
| Current or ex-smoker | 47 (75%) | 14 (74%) |
| Hypertension | 26 (42%) | 7 (37%) |
| Type two diabetes mellitus | 5 (8%) | 1 (5%) |
| Prior MI | 14 (22%) | 11 (58%) |
| Prior stroke | 8 (13%) | 4 (21%) |
| Prior PVD | 9 (14%) | 4 (21%) |
| Medications | ||
| Aspirin | 48 (76%) | 16 (84%) |
| Statin | 53 (84%) | 19 (100%) |
| Beta-blocker | 21 (33%) | 10 (53%) |
| ACEI or ARB | 30 (48%) | 13 (68%) |
ACEI, ACE inhibitor; ARB, angiotensin-receptor blocker; MI, myocardial infarction; PVD, peripheral vascular disease.